Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Russo, IH; Russo, J
   Hormonal approach to breast cancer prevention
   JOURNAL OF CELLULAR BIOCHEMISTRY
   
   I.H. Russo e J. Russo, "Hormonal approach to breast cancer prevention", J CELL BIOC, 2000, pp. 1-6
2. Al-Shebaily, MM
   Evaluation of the effects of pregnyl on pituitary-ovarian hormones and biochemical markers of tissue injury in female Swiss albino mice
   RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
   
   M.M. Al-Shebaily, "Evaluation of the effects of pregnyl on pituitary-ovarian hormones and biochemical markers of tissue injury in female Swiss albino mice", RES COM M P, 105(1-2), 1999, pp. 155-171
3. Toppari, J; Kaleva, M
   Maldescendus testis
   HORMONE RESEARCH
   
   J. Toppari e M. Kaleva, "Maldescendus testis", HORMONE RES, 51(6), 1999, pp. 261-269
4. OSUNA JA; DEBELLABARBA GA; TEMPONI AF; OSUNA A; MARIN CR
   CRYPTORCHIDISM - TREATMENT WITH HUMAN CHORIONIC-GONADOTROPIN - A VENEZUELAN EXPERIENCE
   Archives of andrology
   
   J.A. Osuna et al., "CRYPTORCHIDISM - TREATMENT WITH HUMAN CHORIONIC-GONADOTROPIN - A VENEZUELAN EXPERIENCE", Archives of andrology, 39(3), 1997, pp. 229-235
5. HIKIM APS; SWERDLOFF RS
   TIME-COURSE OF RECOVERY OF SPERMATOGENESIS AND LEYDIG-CELL FUNCTION AFTER CESSATION OF GONADOTROPIN-RELEASING-HORMONE ANTAGONIST TREATMENT IN THE ADULT-RAT
   Endocrinology
   
   A.P.S. Hikim e R.S. Swerdloff, "TIME-COURSE OF RECOVERY OF SPERMATOGENESIS AND LEYDIG-CELL FUNCTION AFTER CESSATION OF GONADOTROPIN-RELEASING-HORMONE ANTAGONIST TREATMENT IN THE ADULT-RAT", Endocrinology, 134(4), 1994, pp. 1627-1634